Company: TELO
Filing Date: 2025-11-28
Form Type: PRER14A
Source: 0001493152-25-025406
Chunk: 6

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-28
Form: PRER14A
Chunk 6
---
 OF CONTENTS</div>

| QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER |  1 |
| SUMMARY                                                        |  8 |
| MARKET PRICE AND DIVIDEND INFORMATION                          | 13 |
| RISK FACTORS                                                   | 14 |
| THE MERGER                                                     | 28 |
| THE MERGER AGREEMENT                                           | 38 |
| DESCRIPTION OF TELI’S BUSINESS                                 | 42 |
| MATTERS BEING SUBMITTED TO A VOTE OF TELO’S STOCKHOLDERS       | 54 |
| PRINCIPAL STOCKHOLDERS OF TELOMIR PHARMACEUTICALS, INC.        | 75 |
| FUTURE STOCKHOLDER PROPOSALS                                   | 76 |
| AVAILABILITY OF ANNUAL REPORT ON FORM 10-K                     | 76 |
| STOCKHOLDERS SHARING THE SAME LAST NAME AND ADDRESS            | 77 |
| INFORMATION INCORPORATED BY REFERENCE                          | 77 |
| WHERE YOU CAN FIND MORE INFORMATION                            | 77 |

| i |

<div align='center'>QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING AND THE MERGER</div>

The following section provides answers to frequently asked questions about Telomir Pharmaceuticals, Inc.’s (“TELO”, or “the Company”) annual meeting of shareholders (the “Annual Meeting”) and more specifically, the proposed Merger. This section, however, provides only summary information. For a more complete response to these questions and for additional information, please refer to the cross-referenced sections.

Q: When and where is the TELO Annual Meeting?

A:The TELO Annual Meeting will be held exclusively online via live audio-only webcast on December 30, 2025, promptly at 10:00 A.M. Eastern Time. Please note that you will not be able to attend the TELO Annual Meeting in person.

Q: Who is entitled to vote at the Annual Meeting?

A:The Board has fixed the close of business on November 3, 2025 as the record date (the “Record Date”) for a determination of the stockholders entitled to notice of, and to vote at, the Annual Meeting. As of the Record Date, there are 34,380,971 shares of Common Stock of the Company outstanding. Each share of the Common Stock represents one vote that may be voted on each matter that may come before the Annual Meeting.

Q: May I ask questions at the Annual Meeting?

A